4 hours ago • egyptoil-gas.com
Egypt Launches Initiative to Treat Petroleum Waste, Extract Strategic Minerals
4 hours ago • egyptoil-gas.com
Egypt Launches Initiative to Treat Petroleum Waste, Extract Strategic Minerals4 hours ago • news-medical.net
New combination treatment helps people with recurring grade 3 astrocytoma, trial shows4 hours ago • starnewsonline.com
Another $1 million dumped in delayed Brunswick water treatment project4 hours ago • PR Newswire
New Symptom-Management Guide Offers Practical Support for People Undergoing Metastatic Breast Cancer Treatment4 hours ago • businesswire.com
Stoke Therapeutics and Biogen Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting4 hours ago • constructionworld.in
Centre Expands Projects to Improve Groundwater Levels Nationwide5 hours ago • PR Newswire
Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment Capabilities for Leading Arizona Surgeon8 hours ago • healthcareasiamagazine.com
Santen–SERI $16.2m project targets glaucoma, myopia treatment9 hours ago • post-gazette.com
Treatment of carotid artery disease could be reshaped by 10-year clinical trial9 hours ago • globenewswire.com
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)20 hours ago • PR Newswire
ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed2025-12-07 • PR Newswire
Zenocutuzumab-zbco (BIZENGRI®) Shows Durable Efficacy in Patients with Treatment-Naïve NRG1+NSCLC: Updated eNRGy Trial Results Presented at IASLC-ASCO NACLC2025-12-06 • PR Newswire
Earlier use of CARVYKTI® demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma2025-12-06 • quiverquant.com
Rep. Foushee Announces $1 Million Federal Funding for Water Treatment Safety Upgrade in Hillsborough2025-12-06 • quiverquant.com
CG Oncology Reports Promising Efficacy and Safety Data for Cretostimogene in High-Risk Non-Muscle Invasive Bladder Cancer Trials2025-12-06 • quiverquant.com
ORIC Pharmaceuticals Reports Promising Preliminary Data for Enozertinib in 1L EGFR PACC Patients with High Response Rates and Favorable Safety Profile2025-12-06 • medcitynews.com
Crescent Bio Expands Its Cancer Drug Combo Ambitions With New Kelun-Biotech Alliance2025-12-06 • multiplesclerosisnewstoday.com
FDA clears clinical trials for Lynk’s oral MS therapy2025-12-06 • fiercebiotech.com
The FDA has placed a hold on Denali Therapeutics’ plans to launch a phase 1 rare disease trial, citing concerns about immune reactions to the investigational treatment recorded in preclinical mouse studies. The regulator has requested that Denali adjust its trial protocol “to include a lower starting dose, revised inclusion criteria, certain safety monitoring commitments and stopping rules,” the Bay Area biotech said in a Dec. 4 filing with the Securities and Exchange Commission (SEC). The FDA identified the concerns during its 30-day review of Denali's Investigational New Drug (IND) application for an enzyme replacement therapy dubbed DNL952. The agency is not asking the biotech to conduct any additional preclinical research. “We have submitted our response to the FDA and plan to start the phase 1 study in the first half of 2026, pending the agency’s feedback,” a Denali spokesperson told Fierce Biotech. Denali doesn't expect the hold to significantly delay its phase 12025-12-06 • manilatimes.net
New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer2025-12-06 • fabrydiseasenews.com
Fabry treatment ST-920 boosts kidney, heart function in trial2025-12-06 • genengnews.com
Resistant Ovarian Cancer Combination Therapy Shows Promise2025-12-06 • eurekalert.org
World's first mitochondrial disease treatment 'MA-5' commences Phase II clinical trial2025-12-06 • medicalxpress.com
Recent trial reveals promising therapy for aggressive brain cancer2025-12-06 • businesswire.com
Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial2025-12-06 • investors.biogen.com
Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting2025-12-06 • castanet.net
Concerns over sewage treatment plant smell spills over in council meeting2025-12-06 • wvua23.com
Guin getting $250K grant for wastewater treatment upgrades2025-12-06 • alchempro.com
Hawkins acquires Redbird Chemical to boost Texas expansion2025-12-06 • news-medical.net
University of Iowa research finds an effective therapy for rare kidney disease in children2 minutes ago • newswire.ca
Canadian Investment Regulatory Organization Trade Resumption - LIS2 hours ago • prnewswire.co.uk
Cardiovascular Diagnostic Device Market to Reach $21.1 billion, Globally, by 2034 at 7.2% CAGR: Allied Market Research3 hours ago • newswire.ca
STATEMENT - Canadian Medical Association welcomes new federal measures to fast-track international doctors3 hours ago • retailtechinnovationhub.com
Warehouse and store automation specialist GreyOrange appoints Deepak Sharma as Chief Operating Officer3 hours ago • dailymail.co.uk
Moment Pregnant Girlfriend Proposed Drug Dealing Boyfriend Unaware Police Bust 26million Trafficking Racket.html3 hours ago • wastemanagementreview.com.au
Australia’s reach for global circularity rate and $26 billion boost3 hours ago • hampshire.police.uk
Two Charged In Southampton Murder Investigation3 hours ago • thedefensepost.com
Burkina Faso Releases 8 NGO Members Arrested for ‘Spying’3 hours ago • thedefensepost.com
US OKs Sale of JASSM-ER Missiles to Italy, GBU-39/B Bombs to S. Korea3 hours ago • sentinelassam.com
Assam Approves Transfer of 3,000 Bighas Land for Silchar Greenfield Airport3 hours ago • realestate.com.au
Inside the only South Melbourne project with 45+ lifestyle amenities3 hours ago • cbn.com.cy
Bird Aviation gets Environment Department green light for new aircraft maintenance buildingJust now • EIN Presswire
JoJo Bee, Canadian Author, Invites Readers into the World of Airabeth with a Special Holiday Promotion Dec. 15–22, 20251 minute ago • PR Newswire
EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide1 minute ago • PR Newswire
NDUR for Athletes Partners with Boston Public Schools for Second Year to Strengthen Student-Athlete Mental Health & Wellness4 hours ago • defensemirror.com
Russia Lays Out New Transport Aircraft, Large Passenger Jet Plans7 hours ago • tvbrics.com
Omsk launches production of strategic raw materials for aviation and industry3 hours ago • exchange4media.com
Fintech startup Aspora has appointed Varun Sridhar as CEO3 hours ago • sentinelassam.com
Assam Approves Transfer of 3,000 Bighas Land for Silchar Greenfield Airport3 hours ago • india.com
Good news for THIS company as it wins Rs 277-crore NHAI projects in Tamil Nadu, Maharashtra46 minutes ago • EIN Presswire
Buxton’s New Inn Celebrates 1st Birthday with CAMRA ‘Pub of the Season’ Award2 hours ago • EIN Presswire
Stone Talent Partners Joins Evertreen to Support Global Reforestation Efforts2 hours ago • EIN Presswire
Vantisco Partners with Evertreen to Support Global Reforestation EffortsStay ahead with real-time headlines from top sources, categorized by sector and country.